PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded ...

Astellas Pharma is slowing things down in the inaugural consumer-facing marketing blast for eye disease drug Izervay. | ...

Astellas is rolling out its first DTC campaign to raise awareness about an injection that treats geographic atrophy.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Şeyma will report directly to the President of International Markets and will be based in Istanbul. As a member of the ...

New data show excellent quality-of-life outcomes and effective tumor control for both intensity-modulated radiation therapy ...

IMTOZ trial findings and subsequent approval of Isa-VRd regimen for transplant-ineligible myeloma suggested the combo as a ...

While they were both approved several years back to treat the same two types of prostate cancer, Astellas and Pfizer’s Xtandi ...

The Federal Circuit has vacated a District of Delaware ruling in a patent case which found that patent claims asserted by ...

Astellas has failed to heed warnings about not following the UK pharma industry code, and has only narrowly avoided being expelled from industry membership. In a damning appraisal, the company's ...